It has recently been shown that the monoclonal antibody JAQ1 to murine glycoprotein VI (GPVI) can cause aggregation of mouse platelets upon antibody crosslinking and that collagen-induced platelet aggregation can be inhibited by preincubation of platelets with JAQ1 in the absence of cross-linking (Nieswandt, B., Bergmeier, W., Schulte, V., Rackebrandt, K., Gessner, J. E., and Zirngibl, H. (2000) J. Biol. Chem. 275, 23998 -24002). In the present study, we have shown that crosslinking of GPVI by JAQ1 results in tyrosine phosphorylation of the same profile of proteins as that induced by collagen, including the Fc receptor (FcR) ␥-chain, Syk, LAT, SLP-76, and phospholipase C␥2. In contrast, platelet aggregation and tyrosine phosphorylation of these proteins were inhibited when mouse platelets were preincubated with JAQ1 in the absence of cross-linking and were subsequently stimulated with a collagen-related peptide (CRP) that is specific for GPVI and low concentrations of collagen. However, at higher concentrations of collagen, but not CRP, aggregation of platelets and tyrosine phosphorylation of the above proteins (except for the adapter LAT) is re-established despite the presence of JAQ1. These observations suggest that a second activatory binding site, which is distinct from the CRP binding site on GPVI on mouse platelets, is occupied in the presence of high concentrations of collagen. Although this could be a second site on GPVI that is activated by a novel motif within the collagen molecule, the absence of LAT phosphorylation in response to collagen in the presence of JAQ1 suggests that this is more likely to be caused by activation of a second receptor that is also coupled to the FcR ␥-chain. The possibility that this response is mediated by a receptor that is not coupled to FcR ␥-chain is excluded on the grounds that aggregation is absent in platelets from FcR ␥-chain-deficient mice.The platelet collagen receptor GPVI 1 plays a pivotal role in platelet activation following receptor cross-linking by collagen. This is highlighted by the impaired response to collagen in GPVI-deficient patients (2-4) and the bleeding disorders associated with this. GPVI is a 60 -65-kDa type I transmembrane glycoprotein belonging to the immunoglobulin superfamily (5), which forms a complex with the FcR ␥-chain at the cell surface in human and mouse platelets (1, 6, 7). Signaling through GPVI occurs via a similar pathway to that used by immunoreceptors (8) as revealed by the tyrosine phosphorylation of the FcR ␥-chain immunoreceptor tyrosine-based activation motif (ITAM) by a Src-like kinase (9, 10). The Src-like kinases Fyn and Lyn are believed to be involved in this phosphorylation (9 -11). Syk is able to bind to the tyrosine-phosphorylated ITAM of the FcR ␥-chain via its tandem SH2 domains (12) leading to autophosphorylation and activation. Syk plays a critical role in the regulation of PLC␥2 through phosphorylation of a number of key proteins including the adapters LAT and SLP-76 (13-15). These signaling events occur upon colla...